 | Issue navigator |
|
|
Contents of Volume 7 Suppl 1
VI Madrid Breast Cancer Conference: Changes in the treatment of breast cancer
Meeting abstracts
Madrid, Spain. 1  3 June 2005
|
Poster presentation
Cyclo-oxygenase-2 expression is associated with poor clinical outcome after doxorubicin-based chemotherapy in node-positive breast cancer: integration of tissue microarray
SH Han, JS Kim, SS Jung, BJ Song
Breast Cancer Research 2005, 7(Suppl 1):P1 (27 May 2005)
[Full text] [PDF]
Poster presentation
Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
IP Callejo, J Brito, R Alves, P Dias, M Limbert, N Abecasis, J Faria, J Weinholtz, S André, C Costa, O Almeida, M e Sousa
Breast Cancer Research 2005, 7(Suppl 1):P2 (27 May 2005)
[Full text] [PDF]
Poster presentation
Fibroadenoma of breast in Iranian women between 1994 and 2004
A Abdollahi, S Shalbaf
Breast Cancer Research 2005, 7(Suppl 1):P3 (27 May 2005)
[Full text] [PDF]
Poster presentation
Nanoparticulate paclitaxel loaded into sterically stabilized mixed phospholipid micelles to improve chemotherapy of breast cancer
I Rubinstein, A Krishnadas, LR Peddakota, H Önyüksel
Breast Cancer Research 2005, 7(Suppl 1):P4 (27 May 2005)
[Full text] [PDF]
Poster presentation
6-(1-oxobutyl)-5,8-dimetoxy-1,4-naphthoquinone inhibits the growth of MCF-7 cells via inhibition of angiogenesis and hypoxia inducible factor alpha
S-H Kim
Breast Cancer Research 2005, 7(Suppl 1):P5 (27 May 2005)
[Full text] [PDF]
Poster presentation
Clinical profile and management of bilateral breast cancer
V Suryanarayana Deo, D Shridhar, NK Shukla, S Kumar, J Purkayastha, V Raina, GK Rath
Breast Cancer Research 2005, 7(Suppl 1):P6 (27 May 2005)
[Full text] [PDF]
Poster presentation
Adjuvant radiotherapy after surgery in breast cancer: evaluation of acute toxicity
MA Molinaro, C Vaccaro
Breast Cancer Research 2005, 7(Suppl 1):P7 (27 May 2005)
[Full text] [PDF]
Poster presentation
Breast cancer-screening programme amongst unpriviledged women in Charleroi (Hainaut), Belgium
F Bastin, M Lejeune
Breast Cancer Research 2005, 7(Suppl 1):P8 (27 May 2005)
[Full text] [PDF]
Poster presentation
A performance study of different soft-computing procedures for automatic detection of breast cancer malignancy
M Ortega-Moral, V Gómez-Verdejo, J Arenas-García, LA Azpicueta-Ruiz, M Lázaro-Gredilla, J Madrid-Sánchez, E López-Beltrán, AR Figueiras-Vidal
Breast Cancer Research 2005, 7(Suppl 1):P9 (27 May 2005)
[Full text] [PDF]
Poster presentation
A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
A Bensalem, K Bouzid
Breast Cancer Research 2005, 7(Suppl 1):P10 (27 May 2005)
[Full text] [PDF]
Poster presentation
The axillary study with ultrasound and cytological puncture with fine needle in invasive breast cancer.
M Izquierdo, M Cusido, D Dexeus, J Feu, F Tresserra, C Ara, B Navarro, L Lopez Marin, R Fabregas
Breast Cancer Research 2005, 7(Suppl 1):P11 (27 May 2005)
[Full text] [PDF]
Poster presentation
Expression of c-met gene in invasive ductal carcinomas
CH Park, MH Lee, ES Chang, BJ Song, SS Jung
Breast Cancer Research 2005, 7(Suppl 1):P12 (27 May 2005)
[Full text] [PDF]
Poster presentation
[ASCRIT] Antisense chemoradioimmunotherapy consisting of anti-POEM (Arg-Gly-Asp) scFv linked onto high-energy radioisotopes, vinorelbine-tartrate and 21-nucleotide double-stranded siRNA targeted to DNMT1 induce apoptosis in metastatic breast cancer (MBC) characterized by hypermethylated p53, p16, RASSF1A, RAR-b2, BRCA2, H1C1, ESRI1, CDH1, Trbeta1, GSTP1, CCND2 and overexpression of bcl-2, cdc25c, Raf-1 and  8 1 integrin
J Giannios, P Lambrinos, E Maragudakis, N Alexandropoulos
Breast Cancer Research 2005, 7(Suppl 1):P13 (27 May 2005)
[Full text] [PDF]
Oral presentation
The role of gene expression profiling by microarray analysis for prognostic classification of breast cancer
MJ van de Vijver
Breast Cancer Research 2005, 7(Suppl 1):S1 (27 May 2005)
[Full text] [PDF]
Oral presentation
Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
JGM Klijn, EMJJ Berns, J Martens, MPHM Jansen, D Atkins, JA Foekens, Y Wang
Breast Cancer Research 2005, 7(Suppl 1):S2 (27 May 2005)
[Full text] [PDF]
Oral presentation
Methods for gene expression profiling in clinical trials for breast cancer
S Paik
Breast Cancer Research 2005, 7(Suppl 1):S3 (27 May 2005)
[Full text] [PDF]
Oral presentation
Gene expression profile-based predictors of response to chemotherapy
L Pusztai
Breast Cancer Research 2005, 7(Suppl 1):S4 (27 May 2005)
[Full text] [PDF]
Oral presentation
Present situation and future of genetic profiling for prognosis and treatment
GN Hortobagyi
Breast Cancer Research 2005, 7(Suppl 1):S5 (27 May 2005)
[Full text] [PDF]
Oral presentation
The role of magnetic resonance imaging as an imaging tool to assess disease status and residual disease in locally advanced breast cancer
M Cristofanilli
Breast Cancer Research 2005, 7(Suppl 1):S6 (27 May 2005)
[Full text] [PDF]
Oral presentation
The roles of PET and CT/PET as preoperative studies
RC Delgado-Bolton, JL Carreras Delgado
Breast Cancer Research 2005, 7(Suppl 1):S7 (27 May 2005)
[Full text] [PDF]
| |
|  |
